In ₹ Crore except Per Share Latest Annual	JYOTHYLAB FY26	HINDUNILVR FY26	GODREJCP FY26	DABUR FY26	Peer Average
Valuation — at last close
P/E	◆ 19.30×	28.30×	56.52×	44.00×	42.94× -55%
P/B	◆ 4.05×	8.87×	10.92×	8.72×	9.50× -57%
EV/EBITDA	◆ 12.47×	29.71×	38.97×	34.88×	34.52× -64%
Market Cap	₹6,428 Cr	₹4.37L Cr	₹85,642 Cr	₹65,627 Cr	₹1.96L Cr -97%
Growth
Revenue CAGR 3Y	5.86%	1.57%	◆ 7.31%	2.61%	3.83% +53%
Revenue CAGR 5Y	◆ 9.33%	6.14%	8.66%	5.48%	6.76% +38%
Net Income CAGR 3Y	11.63%	◆ 15.69%	0.04%	2.78%	6.17% +88%
Revenue YoY (latest Q)	2.95%	◆ 12.56%	11.00%	8.82%	10.79% -73%
Net Income YoY (latest Q)	-50.78%	5.72%	-5.31%	◆ 11.05%	3.82% -1429%
Profitability
EBITDA Margin	15.28%	23.34%	◆ 23.60%	18.98%	21.97% -30%
Net Income Margin	11.32%	◆ 24.89%	16.00%	15.89%	18.93% -40%
Return on Common Equity	22.43%	◆ 31.36%	18.70%	19.95%	23.34% -4%
Return on Capital Employed	◆ 24.22%	21.13%	23.72%	19.29%	21.38% +13%
Return on Assets	15.58%	◆ 19.74%	11.34%	13.09%	14.72% +6%
Credit & Quality
Total Debt/Equity	◆ 0.00×	0.00×	0.36×	0.07×	0.14× -100%
Interest Coverage	◆ 77.88×	36.58×	10.43×	18.47×	21.83× +257%
Scale — latest FY
Revenue / Total Income	₹2,944 Cr	₹61,975 Cr	₹9,474 Cr	₹9,383 Cr	₹26,944 Cr -89%
Net Income	₹333 Cr	₹15,427 Cr	₹1,516 Cr	₹1,491 Cr	₹6,145 Cr -95%
Total Assets	₹2,252 Cr	₹77,982 Cr	₹13,365 Cr	₹11,773 Cr	₹34,373 Cr -93%
EPS	₹9.07	₹65.66	₹14.81	₹8.41	₹29.63 -69%
Book Value per Share	₹43.26	₹209.46	₹76.67	₹42.44	₹109.52 -61%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.